Clinical trials for Neuroendocrine neoplasm
12 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT06202066Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine CarcinomasRoswell Park Cancer Institute · PI: Jasmeet Kaur, MD
- RECRUITINGNCT06282016Risk Factors for Neuroendocrine NeoplasmsBavarian Cancer Registry · PI: Jacqueline Müller-Nordhorn
- RECRUITINGPhase 2NCT07077551NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm TrialSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT06276309Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine TumorsFujian Maternity and Child Health Hospital · PI: Pengming Sun, PhD
- RECRUITINGPhase 3NCT05918302Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.Grupo Espanol de Tumores Neuroendocrinos · PI: Jaume Capdevila, M.D. Ph.D.
- RECRUITINGNCT06402695Observational Study on GEP-and Pulm-NET Treated at FPGFondazione Policlinico Universitario Agostino Gemelli IRCCS · PI: Giovanni Schinzari
- RECRUITINGPhase 2NCT05879055A Study of PM8002 in Combination With Chemotherapy in Patients With NENBiotheus Inc. · PI: Jianming Xu
- RECRUITINGNCT06337760YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.European Institute of Oncology · PI: Francesca Spada, MD
- RECRUITINGN/ANCT06523582Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsUniversidad Nacional Autonoma de Mexico · PI: Laura C Hernández Ramírez, MD, PhD
- RECRUITINGN/ANCT06279299Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric ExcisionNational Cancer Center, China · PI: Haitao Zhou
- RECRUITINGPhase 2NCT04893785A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)National Cancer Institute, Naples
- ACTIVE NOT RECRUITINGPhase 2NCT04079712Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine TumorsNational Cancer Institute (NCI) · PI: Adel Mandl